A cohort study found that nearly three fourths of infants received respiratory syncytial virus protection with either nirsevimab or through exposure to maternal RSVpreF in the 2023-2024 season.

Introduction: Respiratory syncytial virus (RSV) vaccines targeting the fusion glycoprotein (F protein ... BioLegend), Brilliant Violet 510 anti-mouse/human CD44 antibody (clone: IM7, catalog numbers: ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

With rising temperatures and the start of the spring semester, Peng said that campuses will be coping with the increased risk ...

The overall number of respiratory virus cases in hospital emergency departments dropped for the second consecutive week — a ...

In the post-COVID-19 era, the co-circulation of respiratory viruses, including influenza, SARS-CoV-2, and respiratory syncytial virus (RSV), continues to have significant health impacts and presents ...

RSV patients treated with antiviral drug S-337395 showed statistically significant reduction in viral load S-337395 is ...

"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...

The Ministry of Public Health yesterday confirmed the discovery of a new coronavirus, HKU5-CoV-2, by a laboratory in China but said no human infections have been recorded as yet.Dr Opas Karnkawinpong, ...

The Ministry of Public Health has verified the identification of a new coronavirus, HKU5-CoV-2, by a laboratory in China, stating that no human infections have been reported to date.

Respiratory syncytial virus (RSV), or human respiratory syncytial virus (hRSV), is a common viral respiratory infection that triggers mild, cold-like symptoms. However, at-risk populations ...